ASKA Pharmaceutical Holdings Co.,Ltd.

TSE:4886 Stock Report

Market Cap: JP¥57.7b

ASKA Pharmaceutical HoldingsLtd Future Growth

Future criteria checks 2/6

ASKA Pharmaceutical HoldingsLtd is forecast to grow earnings and revenue by 1.2% and 4.3% per annum respectively. EPS is expected to grow by 1.2% per annum. Return on equity is forecast to be 7.9% in 3 years.

Key information

1.2%

Earnings growth rate

1.2%

EPS growth rate

Pharmaceuticals earnings growth11.7%
Revenue growth rate4.3%
Future return on equity7.9%
Analyst coverage

Low

Last updated18 Nov 2024

Recent future growth updates

Recent updates

ASKA Pharmaceutical HoldingsLtd's (TSE:4886) Profits May Not Reveal Underlying Issues

Nov 19
ASKA Pharmaceutical HoldingsLtd's (TSE:4886) Profits May Not Reveal Underlying Issues

ASKA Pharmaceutical HoldingsLtd's (TSE:4886) Solid Profits Have Weak Fundamentals

May 21
ASKA Pharmaceutical HoldingsLtd's (TSE:4886) Solid Profits Have Weak Fundamentals

Earnings and Revenue Growth Forecasts

TSE:4886 - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202771,0655,6034,281N/A1
3/31/202666,5204,8281,954N/A2
3/31/202564,0185,1353,808N/A1
9/30/202463,5665,976-3,198-452N/A
6/30/202463,1727,390N/AN/AN/A
3/31/202462,8437,545331,486N/A
12/31/202362,0266,513N/AN/AN/A
9/30/202361,9376,0213,6644,782N/A
6/30/202361,2154,343N/AN/AN/A
3/31/202360,4614,2382,6053,351N/A
12/31/202259,6874,391N/AN/AN/A
9/30/202258,3029,4327963,091N/A
6/30/202257,6554,515N/AN/AN/A
3/31/202256,6074,2904652,842N/A
12/31/202156,0104,344N/AN/AN/A
9/30/202156,255-1,6353,7264,647N/A
6/30/202155,6883,072N/AN/AN/A
3/31/202155,1812,7135,4376,541N/A
12/31/202054,6852,036N/AN/AN/A
9/30/202053,3631,6246,8788,149N/A
6/30/202052,265825N/AN/AN/A
3/31/202052,542649-2,756-492N/A
12/31/201950,897592N/AN/AN/A
9/30/201949,8111,578-4,750-2,317N/A
6/30/201947,9361,245N/AN/AN/A
3/31/201946,7061,744-13,2192,504N/A
12/31/201847,2471,578N/AN/AN/A
9/30/201847,3671,488-15,517269N/A
6/30/201848,8922,407N/AN/AN/A
3/31/201848,9442,388N/A76N/A
12/31/201749,7652,060N/AN/AN/A
9/30/201749,2653,312N/A6,470N/A
6/30/201749,3533,461N/AN/AN/A
3/31/201748,5272,944N/A12,063N/A
12/31/201647,1583,531N/AN/AN/A
9/30/201646,4241,581N/A6,784N/A
6/30/201644,4791,040N/AN/AN/A
3/31/201643,215701N/A-1,349N/A
12/31/201542,721792N/AN/AN/A
9/30/201540,819752N/A605N/A
6/30/201543,1971,085N/AN/AN/A
3/31/201542,9071,193N/A5,710N/A
12/31/201442,335695N/AN/AN/A
9/30/201442,670809N/A3,302N/A
6/30/201439,393282N/AN/AN/A
3/31/201439,501495N/A2,616N/A
12/31/201340,6321,000N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4886's forecast earnings growth (1.2% per year) is above the savings rate (0.3%).

Earnings vs Market: 4886's earnings (1.2% per year) are forecast to grow slower than the JP market (7.9% per year).

High Growth Earnings: 4886's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4886's revenue (4.3% per year) is forecast to grow faster than the JP market (4.1% per year).

High Growth Revenue: 4886's revenue (4.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 4886's Return on Equity is forecast to be low in 3 years time (7.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y